1996•RadiologyRequires access

Lacrimal canaliculus obstruction: nonsurgical treatment with a newly designed polyurethane stent.

H Y Song, C O Lee, Sung Hun Park, Seung Woo Suh, Hyun‐Ki Yoon, Sook‐Kyoung Kang, Kyu‐Bo Sung

Open publisher page 22 citations

Abstract

A newly designed polyurethane stent was used to successfully treat 30 eyes (in 28 patients) with epiphora resulting from obstruction of the lacrimal canaliculus. After stent placement, epiphora resolved in all eyes. During follow-up, epiphora recurred in 20 eyes, but epiphora did not recur and the lacrimal canaliculus was patent in 12 eyes after the stent was removed. The stent appears to be valuable for nonsurgical treatment of obstruction of the lacrimal canaliculus.

About this research paper

What this paper is about

A newly designed polyurethane stent was used to successfully treat 30 eyes (in 28 patients) with epiphora resulting from obstruction of the lacrimal canaliculus. After stent placement, epiphora resolved in all eyes. During follow-up, epiphora recurred in 20 eyes, but epiphora did not recur and the lacrimal canaliculus was patent in 12 eyes after the stent was removed. The stent appears to be valuable for nonsurgical treatment of obstruction of the lacrimal canaliculus.

Why it matters

OpenAlex reports 22 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A newly designed polyurethane stent was used to successfully treat 30 eyes (in 28 patients) with epiphora resulting from obstruction of the lacrimal canaliculus. After stent placement, epiphora resolved in all eyes. During follow-up, epiphora recurred in 20 eyes, but epiphora did not recur and the lacrimal canaliculus was patent in 12 eyes after the stent was removed. The stent appears to be valuable for nonsurgical treatment of obstruction of the lacrimal canaliculus.

Key concepts: Medicine, Lacrimal canaliculi, Stent, Surgery, Dacryocystorhinostomy, Lacrimal apparatus, Bone canaliculus, Lacrimal sac

Related papers

Back to paper searchBrowse research topicsOriginal source
Lacrimal canaliculus obstruction: nonsurgical treatment with a newly designed polyurethane stent. — Research Paper | ScholarLens